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NGSWhole-transcriptome evaluation by next-generation sequencing (NGS) has beenwidely applied in the investiga-
tion of diverse transcriptional scenarios. In many clinical situations, including needle biopsy samples or laser mi-
crodissected cells, limited amounts of RNA are usually available for the assessment of the whole transcriptome.
Here, we describe anmRNAampliﬁcation protocol based on in vitro T7 transcription for transcriptome evaluation
by NGS. Initially, we performed RNAseq from two human mammary epithelial cell lines and evaluated several
aspects of the transcriptomes generated by linear ampliﬁcation of Poly (A)+ mRNA species, including transcript
representation, variability and abundance. Our protocol showed to be efﬁcient with respect to full-length
transcript coverage and quantitative expression levels. We then evaluated the applicability of using this protocol
in a more realistic research scenario, analyzing tumor tissue samples microdissected by laser capture. In order to
increase the quantiﬁcation power of the libraries only the 3′ end of transcripts were sequenced.We found highly
reproducible RNAseq data among ampliﬁed tumor samples, with a median Spearman's correlation of 80%,
strongly suggesting that the ampliﬁcation step and library protocol preparation lead to a consistent transcriptional
proﬁle. Altogether, we established a robust protocol for assessing the polyadenylated transcriptome derived from
limited amounts of total RNA that is applicable to all NGS platforms.
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.1. Introduction
Next-generation sequencing (NGS) technologies allow for deep
transcriptome interrogation at an unprecedented scale. The sequencing
analysis of transcriptomes, RNAseq, has been applied to different
scenarios, including the investigation of transcriptional regulation in
distinct clinical settings (Berger et al., 2010; Tuch et al., 2010;
Sugarbaker et al., 2008; Beane et al., 2011). The deep coverage and
single-base resolution of transcriptome evaluation allows the simul-
taneous observation of gene expression, alternative splicing, RNA
editing, gene fusion, allelic imbalance and mutation events (Tuch
et al., 2010; Maher et al., 2009; Watson et al., 2010; Wilhelm et al.,
2011; Carraro et al., 2011; Park et al., 2012). Due to the complexity
of the molecular mechanisms involved in tumor development and
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genomics research.
Solid tumors are heterogeneous in both their cell type composition
and in the intrinsic genetic variability of tumor cells. Speciﬁc cell types
in this multifaceted landscape can be recovered by techniques such as
laser capture microdissection (LCM), permitting the assessment of
homogeneous cell populations of interest (Tomlins et al., 2007;
Mwamukonda et al., 2010;Morton et al., 2014). LCMprovides transcrip-
tional investigation at the cell level rather than tissue resolution,
allowing comparisons among different cells from the same tumor
(Castro et al., 2008; Schuetz et al., 2006; Ma et al., 2003; Maschietto
et al., 2011), a remarkable tool for studying tumor heterogeneity, as
well as tumor microenvironment (Rozenchan et al., 2009; Sung et al.,
2011). Thus, the combined use of LCM and NGS shall signiﬁcantly im-
prove the sensitivity of transcriptional studies, enabling the evaluation
of inter- and intra-sample variability.
A major drawback of LCM for large-scale transcriptional approaches
is the limited amount of recoverable RNA. In this situation, the use of
mRNA ampliﬁcation methodologies is an interesting approach, leading
to signiﬁcant augment of mRNA. The main challenge of any ampliﬁca-
tion protocol is to preserve the relative transcript levels, enabling
transcriptional levels and events to be faithfully represented. In vitro
linear Poly (A)+ mRNA ampliﬁcation has been repeatedly employed
and exhaustively analyzed through microarray (Wang et al., 2003;
Gomes et al., 2003) and quantitative PCR approaches (Ferreira et al.,
2010a; Goff et al., 2004; Heil et al., 2003; Theophile et al., 2008),
showingno technical-related biases, aswell as an accuratemaintenance
of the relative transcript abundances, with no decline over gene expres-
sion measurements. The use of mRNA ampliﬁcation for RNAseq using
approaches based on PCR (Tang et al., 2010, 2011), T7-linear ampliﬁca-
tion (Sengupta et al., 2011) and the NuGENOvation system (Tariq et al.,
2011) has been evaluated.
Here, we established a customized and versatile method of Poly
(A)+ mRNA ampliﬁcation based on T7 in vitro transcription and DpnII-
restriction for transcriptome sequencing from laser captured microdis-
sected tumor cells. Initially, for investigating the impact of ampliﬁcation
procedure in mRNA representationwe applied our approach to two cell
lines and compared RNAseq data from ampliﬁed RNA to unampliﬁed
libraries (Carraro et al., 2011). The ampliﬁed libraries showed similar
coverage of 5′ and 3′ ends to Poly (A)+ transcriptome and accurate
representation of both high- and low-abundance transcripts, resulting
in a reliable proﬁle of the transcriptome. We then applied an adapted
protocol for evaluating tumor cells captured from nine prostate
adenocarcinoma samples. This modiﬁed approach was based on the
capture of the 3′ end fragment of each transcript using biotinylated
oligo dT and streptavidin magnetic beads. We found high reproducibil-
ity from the ampliﬁed RNAseq data among tumor samples, suggesting
that the ampliﬁcation approach and library protocol allowed a reliable
transcription proﬁle assessment. Altogether, we established a robust
protocol for assessing the transcriptome of homogeneous cell popula-
tions captured from complex tissues, and adjustable for all NGS
platforms, with no evidence of systematic bias introduced by RNA
ampliﬁcation procedure.Table 1
RNAseq data from ampliﬁed and non-ampliﬁed Poly (A)+ mRNA libraries.
Ampliﬁed m
# of sequenced reads 387,671
Average read length 227 bp
Reads aligned to Human Genome 228,606 (5
Reads aligned to RefSeqs 200,975 (8
# of distinct transcripts evaluated 9,790
# of distinct genes evaluated 9,096
ERBB2 expression ratio (C5.2/Hb4a) 542. Results
2.1. Whole transcriptome sequencing using ampliﬁed Poly (A)+ mRNA
Initially, we have evaluated the feasibility of preparing cDNA
libraries from small amounts of total RNA using two human mammary
cell lines. For analyzing transcript structure after library preparation,
we sequenced at GS FLX 454-Roche platform that provides longer
reads which were essential for the evaluation of putative protocol
biases. Brieﬂy, from 50 ng of total RNA from the human mammary cell
lines, HB4a (Stamps et al., 1994) and C5.2 (Harris et al., 1999), we
obtained double-stranded cDNA after one round of linear Poly (A)+
mRNA ampliﬁcation based on T7 in vitro transcription and template-
switching oligonucleotide (TS-oligo) (Matz et al., 1999). As a check-
point, we evaluated the expression levels of the ERBB2 oncogene in
the cDNA from the two cell lines by RT-qPCR, since C5.2 is a derived-
clone from HB4a that overexpresses this oncogene (Harris et al.,
1999). As expected, ERBB2 presented higher expression in C5.2 cells
compared to the HB4a cells (fold change= 35), suggesting that no arti-
facts were introduced during the mRNA ampliﬁcation steps and
allowing the use of these cDNAs for the RNAseq library construction.
Full-length dscDNA molecules were enzymatically digested with DpnII
and ligated to speciﬁc linkers that contained a barcode for multiplex se-
quencing and also the 454-A and -B primers used for sequencing by the
Genome Sequencer FLX System (454-Roche, Switzerland) (Supplemen-
tary Fig. 1).
A total of 387,671 reads was generated with a median size of 227
base pairs (bp) (Table 1), which is about the expected average size
range after DpnII digestion (256 bp). Reads were aligned against the
Human Genome and Ref-Seq database, representing 9,790 distinct
transcripts (22.53% of the Ref-Seq database) and 9,096 individual
genes (Table 1). All sequence reads were deposited in the Sequence
Read Archive (SRA) (accession number SRA048194.1).
We have thus evaluated the expression levels of the ERBB2 oncogene
from the two cell lines based on the RNAseq data by looking at the ratio
of the normalized read count detected for C5.2 to Hb4a, in order to
conﬁrm the suitability of our approach of Poly (A)+mRNAampliﬁcation
for RNAseq. Similarly to the RT-qPCR results, we conﬁrmed a higher
expression of ERBB2 gene in C5.2 cells compared to HB4a cells (fold
change = 54) (Table 1). Given that consistent results regarding ERBB2
gene expression were obtained, we next investigated qualitative and
quantitative aspects of the entire Poly (A)+ transcriptome.
2.2. Whole transcriptome representation using ampliﬁed Poly (A)+ mRNA
To investigate the impact of the mRNA ampliﬁcation procedure on
RNAseq, we evaluated three major aspects regarding the preservation
of the transcriptome: coverage at the 5′ and 3′ ends of transcripts,main-
tenance of the relative-abundance of the transcripts and the representa-
tion of transcript diversity. RNAseq data from the ampliﬁed Poly (A)+
mRNA library were also compared to non-ampliﬁed Poly (A)+ mRNA
libraries of the same cells from our previous study (Carraro et al.,
2011). The non-ampliﬁed Poly (A)+ mRNA libraries (called Poly (A)+RNA Poly (A)+ RNA (Carraro et al., 2011)
802,214
200 bp
9.0%) 651,058 (81.2%)
8.3%) 476,337 (73.16%)
17,887
11,366
18
Fig. 1.Whole transcriptome representation using ampliﬁed Poly (A)+ mRNA. (A) Distribution of RNAseq reads along the full-length mRNAs, from the 5′ end (0) to 3′ end (100). The fre-
quency of readsmapping to each relative position is proportional to the thickness of the bars and is reported in relation to transcript size for both the ampliﬁedmRNA (left) and Poly (A)+
RNA (right) libraries. (B) Evaluation of the quantitative power of the RNAseq libraries. Transcripts from the reference library were ranked according to expression levels and divided into
quantiles, where 0 represents the least abundant and 1.0 represents the most abundant transcripts. The expression level of the genes in each quantile was obtained for the comparative
library. Data were normalized by reads per million. Gene expression data from the ampliﬁed mRNA library (dashed line) was compared to data obtained from the standard Poly (A)+
mRNA library (solid line) (reference library) (left panel); comparison between Poly (A)+mRNA library (dashed line) and the SAGE library (solid line) from the same cell lines (reference
library) (middle panel); comparison between the ampliﬁedmRNA library (dashed line) and SAGE library (solid line) (reference library) (right panel). (C) Representation of transcriptional
diversity assessed by ampliﬁed and non-ampliﬁed Poly (A)+ mRNA libraries. The number of transcripts represented by different sets of randomly selected sequences from the ampliﬁed
mRNAdataset (dashed line) and Poly (A)+RNAdataset (solid line)were compared. An increasing number of sequenceswere selected and thenumber of different geneswas computed for
each library. From an initial set of 10,000 sequences, novel sets were generated by increasing the number of sequences by 10,000 each time until 150,000 sequences were selected.
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sequenced through the Titanium Genome Sequencer FLX System
(454-Roche). Comparative sequencing data is shown in Table 1.
Initially, we evaluated the transcript coverage of the ampliﬁed
library by analyzing the relative read position within the context of
the full-length mRNAs as described (Dias-Neto et al., 2000). This analy-
sis showed proper full-length coverage, with reads encompassing both
the 5′ and 3′ ends of the transcripts (Fig. 1A). Although, a slight lower
representation of reads at the 5′ end compared to the 3′ end was
detected in the ampliﬁed libraries, the percentage of reads mapping to
the 5′ endwas the same for the ampliﬁed and Poly (A)+mRNA libraries
(Table 2), implying that the ampliﬁcation procedure did not lead to
signiﬁcant impairment of full-length representation. Also, the median
size of transcripts mapping at the 5′ end is similar to the remaining
portions of the transcripts. Moreover, the ampliﬁed mRNA libraries
showed an even higher median transcript size (4,721 bp) compared toTable 2
Relative distribution of RNAseq reads over the length of RefSeq transcripts. The number and pe
given for each range (0–10; 11–20; 21–30; 31–40; 41–50; 51–60; 61–70; 71–80; 81–90; 91–100
obtained based on the size of the transcripts represented by each one of the reads positioned i
0–10 11–20 21–30
Number of reads Ampliﬁed mRNA 6,497 10,247 10,705
Poly(A)+ mRNA 28,904 62,550 77,557
Percentage of reads Ampliﬁed mRNA 4% 7% 7%
Poly(A)+ mRNA 4% 10% 12%
Median transcript size (bp) Ampliﬁed mRNA 4,721 4,193 3,528
Poly(A)+ mRNA 3,325 2,341 2,126the Poly (A)+ mRNA (3,325 bp), suggesting that the ampliﬁcation pro-
cedure was not biased towards full-length representation of smaller
transcripts (Table 2).
Next, to assess themaintenance of the transcript relative abundance
we compared the expression proﬁle of the transcripts obtained from the
ampliﬁed Poly (A)+mRNA libraries to the expression proﬁle of the Poly
(A)+ mRNA libraries (Carraro et al., 2011). In this analysis, transcripts
from the Poly (A)+ libraries were grouped into quantiles according to
increasing expression values. Then, we obtained the expression values
of the set of transcripts of each quantile from the ampliﬁed Poly (A)+
mRNA library. Finally, we plotted the average expression value of tran-
scripts from the Poly (A)+ libraries against the average expression
values of the same transcripts from the ampliﬁed Poly (A)+ mRNA li-
brary for each quantile. Accordingly, transcripts from the lower quantile
of the Poly (A)+ libraries had lower average expression values in the
ampliﬁed Poly (A)+ mRNA library and higher abundance transcriptsrcentage of reads according to the 5′ (0) and 3′ end (100) of each sequenced transcript is
) for both the ampliﬁedmRNA and Poly (A)+RNA libraries. Themedian transcript sizewas
n the range.
31–40 41–50 51–60 61–70 71–80 81–90 91–100
14,351 16,904 13,863 19,247 20,507 19,884 16,421
88,215 81,802 82,903 83,838 66,386 56,446 27,828
10% 11% 9% 13% 14% 13% 11%
13% 12% 13% 13% 10% 9% 4%
3,187 3,594 3,351 3,111 2,596 2,644 3,583
1,896 1,919 1,855 2,082 2,445 2,814 3,599
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ampliﬁed Poly (A)+mRNA library (Fig. 1B; Supplementary Table 1). Ad-
ditionally, transcript expression levels of both libraries were compared
to previously published SAGE (Serial Analysis of Gene Expression)
data from the same cell lines (dos Santos et al., 2006). In this analysis,
transcripts were ranked and grouped into quantiles according to in-
creasing expression values of SAGE tags and plotted against the average
expression values of the same set of transcripts obtained from both
libraries of the RNAseq data (Fig. 1B). The quantitative transcriptional
proﬁles from SAGE and from both RNAseq libraries showed comparable
trends in ascending curves (Fig. 1B; Supplementary Table 1), with a
perceptible ﬂatness of both Poly (A)+ mRNA and ampliﬁed Poly (A)+
curves, accentuated in the latter one.
Finally, to assess the transcriptional diversity represented by the
ampliﬁed Poly (A)+ library, we compared the number of different
genes represented by increasing numbers of randomly selected reads
between the ampliﬁed and the Poly (A)+ RNAseq data. A small decrease
in the variability of the genes represented by the ampliﬁed RNA library
was observed when compared to the Poly (A)+ RNA library (Fig. 1C).
Nonetheless, this result might be a reﬂection of the lower sequencing
depth of the ampliﬁed library (200,975 versus 657,513 reads aligned
to RefSeq for, respectively, the ampliﬁed and Poly (A)+ libraries).2.3. Transcriptome sequencing of 3′ end using ampliﬁed Poly (A)+mRNA of
cells captured from prostate tissue by laser capture microdissection
To evaluate the applicability of our approach in a more realistic
cancer research scenario, we captured epithelial tumor cells from nine
prostate adenocarcinoma samples (PCa) by laser microdissection. On
average, 3,200 cells were captured from each sample, total RNA was
extracted and the mRNA was ampliﬁed (Table 3).
In order to increase the representation of the transcripts from each
tumor sample, we adapted our protocol to sequence only their 3′ end.
Using this approach the reads are not dispersed throughout the
transcripts, allowing a deeper and more quantitative coverage of the
transcriptome. We also adapted our protocol for Ion sequencing
platform (Life Technologies, USA), a faster and more cost-effective and
accessible platform than the 454-Roche. The protocol for library con-
struction was similar to the one mentioned above. However, for the 3′
end selection we used an oligo dT conjugated with a biotin molecule
for the double strand cDNA synthesis, which allowed the isolation of
the 3′ fragments by streptavidin coated magnetic particles after enzy-
matic cleavage by DpnII (Fig. 2). Then, adapters containing the Ion se-
quencing primer A and a 6 nt-barcode were ligated to the 5′ end of
the fragments, leading to unidirectional oriented sequencing from the
5′ extremity. The 3′ RNAseq libraries from the nine prostate samples
were pooled and sequenced together on ﬁve runs.
A total of 2,403,435 5′-oriented reads was generated, from which
82% (1,976,515 reads) aligned to the Human Genome and RefSeqTable 3
Sequencing data from 3′-RNAseq of 9 prostate adenocarcinoma samples.
Barcode Number of capture
cellsa
Total RNA
(ng)
RIN % aRNA with smear r
from 200–800 nt
2 2,735 5.6 5.3 76
3 3,112 5.7 5.6 78
10 2,590 27.4 6.1 85
25 3,012 36.2 6.6 81
40 3,800 38.6 3.5 71
45 3,202 ND ND 73
50 3,000 85.2 6.7 79
60 2,660 43.0 3.0 68
70 5,000 34.4 8.3 80
ND — not determined.; RIN - RNA Integrity Number
a Estimative based on the number of laser shoots — 2.5 cells per shoot.database, indicating high quality library preparation and sequencing
(Table 3). On average, each library represented 17,153 distinct tran-
scripts (Table 3). These sequence reads were submitted to the
Sequence Read Archive (SRA) (accession number SRA235863).
We evaluated possible biases due to the ampliﬁcation protocol by
looking to the reproducibility ofmRNAabundance by Spearman's corre-
lation. After comparing gene expression levels between each library to
the average value of all samples we found a high reproducibility
among tumor samples, with a median Spearman's correlation of 80%
(coefﬁcient's value from R = 0.54 to R = 0.84) (Fig. 3A). Similar
correlation's coefﬁcients were obtained considering gene measure-
ments, instead of individual transcripts (Supplementary Fig. 2). In addi-
tion, pairwise Spearman's correlation was calculated between all tumor
samples, also showing high reproducibility on average (coefﬁcient's
median value R = 0.60, varying from R = 0.16 to R = 0.85) (Fig. 3B).
The PCa-70 sample presented the lowest correlation's coefﬁcient
when compared to the average value (54%) and to other tumor samples
(varying from R=0.16 to R=0.51), although no remarkable difference
between PCa-70 and the other eight samples regarding RNA ampliﬁca-
tion, library construction and sequencing (Table 3) were identiﬁed.
Even though we could not detect any feature that disqualiﬁed this par-
ticular sample prior to sequencing, the fact that its transcriptional pro-
ﬁle was much more variable than the rest of the samples suggests that
artifacts during RNA ampliﬁcation or library construction might have
occurred. Thus, we have excluded this sample from the analysis and
re-evaluated the pairwise Spearman's correlations (Fig. 3B), which
showed a slight increase to R = 0.62 (ranging from R = 0.48 to R =
0.85). Thus, we suggest that the correlation analysis could be used as a
quality parameter of RNAseq data for excluding outliers when using
RNA ampliﬁcation.3. Discussion
RNA ampliﬁcation has been extensively applied for gene expression
investigations, given that only a low amount of total RNA is available.
This approach has been especially useful in cancer research, where gene
expression evaluation based solely on cells of interest were done, rather
than from the tumor tissues as awhole. The limited amounts of RNAgath-
ered from single cells or laser microdissected samples for transcriptional
assessment is amajor obstacle that needs to be overcome inRNAseq anal-
ysis. In this study, we propose a protocol for RNAseq library construction
from laser captured microdissected cells based on one round of linear
RNAampliﬁcation. Initially, to test for protocol biases, especially regarding
transcript structure and the sub-representation of the 5′ end, we
performed RNAseq from two cell lines, which differ signiﬁcantly in its
ERBB2 expression levels. The use of these two cell lines and of the GS
FLX (454-Roche) platform was due to the possibility to compare with
our previous RNAseq data obtained from total RNA (Carraro et al., 2011)
and also due to the 454-Roche capability of generating longer and higherange aRNA
(ng)
Number of
reads
Mapped
reads
% mapped
reads
Number of
transcripts
199 391,663 329,334 84% 19,053
270 183,765 143,678 78% 14,899
147 596,308 503,754 84% 22,629
140 480,716 410,411 85% 21,011
232 242,634 184,333 76% 18,650
89 109,019 89,687 82% 15,116
333 165,965 133,592 80% 15,363
152 114,206 81,964 72% 11,510
763 119,159 99,762 84% 11,999
Fig. 2. Schematic representation of 3′ end RNAseq library approach using ampliﬁedmRNA.
Total RNA obtained from laser microdissected cells were submitted to one round of linear
mRNA ampliﬁcation with Arcturus™ RiboAmp® PLUS Kit (Arcturus). The ampliﬁed anti-
sense RNAwas reverse transcribed using random oligo (dN6) and the second-strand syn-
thesis was performed with biotinylated-oligo dT containing the Ion-P1 sequence primer.
After enzymatic cleavagewithDpnII themost 3′-fragment of each transcript was captured
by streptavidin coated magnetic particles. The captured fragments were coupled to
cohesive linkers containing a 6 nucleotide barcode, speciﬁc for each tumor sample, and
the Ion-A sequence primer, leading to unidirectional oriented sequencing from the 5′
extremity (primer Ion-A).
224 E.N. Ferreira et al. / Gene 564 (2015) 220–227quality reads than Ion semiconductor sequencing, allowing a more accu-
rate assessment of the structural aspects of the library.
RNAseq data fromampliﬁed RNAconﬁrmed thehigher expression of
ERBB2 oncogene on the C5.2 cells, as well as showed suitable data
regarding several aspects of transcriptome, such as coverage and the
quantitative power and representation of the transcripts diversity.Despite the fact that we have detected a small reduction in the
number of readsmapping to the 5′ end compared to the reads mapping
to the 3′ end of transcripts in the ampliﬁed library, no bias towards the
representation of the 5′ of smaller transcripts were identiﬁed. Indeed,
the average size of transcripts with preserved 5′-ends was even higher
than the average size of transcripts, where the central or the 3′ end of
the transcripts was represented (Fig. 1A). As we used an approach
based on TS-oligo ampliﬁcation, which is expected to generate cDNA
molecules enriched for full-length transcripts, overcoming the inefﬁ-
ciency of reverse transcriptase in completely converting mRNA into
complementary DNA (cDNA) (Matz et al., 1999; Ferreira et al.,
2010b); we were able to minimize the underrepresentation of 5′ ends,
especially for longer mRNAs.
One concern about RNA ampliﬁcation approaches lies in their ability
to accurately recapitulate the relative transcriptional levels among all
sequencedmolecules. The quantitative power of RNAseq data from am-
pliﬁed mRNA libraries compared to that of the Poly (A)+ RNA libraries
suggested that although there is a little loss of proportion in the relative
gene expression, similar trends of expression were seen, and more im-
portantly, no inversion in the relative expression levels were detected.
Nonetheless, due to the reduced read depth of the Poly (A)+ and
especially the ampliﬁed libraries, a direct correlation analysis was not
possible.
In terms of gene representation, a decrease in the transcript diversity
was observed for the ampliﬁed Poly (A)+ RNA libraries when compared
to the non-ampliﬁed, which may be due to the decreased sequencing
depth in the ampliﬁed RNA library (200,975 against 657,513 reads
aligned to the RefSeq Database). In this sense, a lower sequencing
depth could have prevented the representation of the low-abundance
transcripts. Moreover, we suspected that this low diversity could result
from an artiﬁcial over-representation of somehighly abundant spurious
transcripts that may have inﬂuenced in decreasing the transcript vari-
ability in the ampliﬁed libraries. We could also ﬁnd an artifactual
over-representation of some genes due to internal TS priming during
the construction of the ampliﬁed cDNA libraries. This issuewas elucidat-
ed by theﬁndingofDpnII-recognition sequence ‘GATC’ in reads originat-
ed from transcripts that did not originally present the DpnII-restriction
site (Supplementary Table 1). The most over-represented gene,
MALAT1, constituted 8% of the sequencing reads in the ampliﬁed Poly
(A)+ RNA library (15,936 reads in total), whereas it only comprised a
small portion of the non-ampliﬁed library (0.0014%). Even so, this
shortcoming was restricted to a small fraction of genes that could be
easily detected and ﬁltered out from the analyses after the search for
DpnII sites. This fact also illustrates the advantages of using DpnII
digestion for the identiﬁcation of artifacts generated during RNAseq
library construction, either for the detection of highly expressed
spurious transcripts and/or spurious gene fusion events (Carraro et al.,
2011). Nonetheless, a careful design of TS-primers, avoiding any
similarity to human transcripts, could easily prevent possible internal
priming artifacts.
Having compared different aspects of the transcriptome of ampliﬁed
and non-ampliﬁed Poly(A)+ we then evaluated the applicability of
using this protocol for tumor tissue samples submitted to LCM. The
use of RNA ampliﬁcation is an essential procedure for many cancer-
driven studies when only tiny quantities of cells or DNA/RNA are
available, such as needle biopsies and laser microdissection. In this
case, we applied a 3′ end RNAseq approach that improves sequencing
depth enhancing gene expression analysis.
We sequenced nine prostate adenocarcinoma samples at Ion PGM
platform. Regarding mRNA measurements, all but one of libraries
showed high reproducibility by Spearman's correlation (higher than
R=0.70), indicating that this is a reliable approach for gene expression
analysis by RNAseq from minute amount of total RNA. The use of
Spearman's correlation analysis was also important for identifying out-
lier samples. By careful analysis of the sample characteristics prior to the
NGS none remarkable differencewas detected in sample PCa-70, which
Fig. 3. RNAseq reproducibility among nine prostate adenocarcinoma samples. (A) Heatmap of Spearman's correlation coefﬁcient for each pairwise comparison and also for each sample
against the mean value considering the nine PCa samples. (B) Heatmap of Spearman's correlation coefﬁcient for pairwise comparisons and also for each sample against the mean value
considering excluding the outlier sample PCa-70. The numbers in each square represent the correlation's coefﬁcient. Thedata is based on the expression values obtained for each transcript.
225E.N. Ferreira et al. / Gene 564 (2015) 220–227behaved as an outlier when compared to the others. The only little dif-
ference was the higher aRNA yield, which was almost four times the
yield quantiﬁed from the other samples (Table 3). Even though this
sample had higher number of captured cells, it was only 1,5 times
higher than the remaining samples, and does not explain the
surprisingly large amount of aRNA produced. In a previous work,
we showed that yields of aRNA higher than expected might be
indicative of artefactual ampliﬁcations probably generated by
using primer dimers as template in the in vitro transcription reac-
tion (Saraiva et al., 2006). Thus, our suggestion is to include the
Spearman's correlation analysis as a quality parameter to ensure
that no bias was introduced in the transcriptional proﬁle by either
RNA ampliﬁcation, or library construction protocols.
The use of RNAseq in many important biological questions
requires the use of different approaches to increase mRNA amounts
when the RNA input is a limitation. Single cell transcriptome eval-
uation has been recently demonstrated to use PCR-based strategy
for RNAseq (Tang et al., 2010, 2011). However due to the exponen-
tial nature of the ampliﬁcation reactions, it is likely that the PCR-
based transcriptome proﬁles may lead to unreliable determination
of expression levels and thus, a comparative analysis to a non-
ampliﬁed sample is necessary. On the other hand, in accordance
to our data, linear ampliﬁcation approaches have also been applied
before to RNAseq from limited amounts of total RNA (Tang et al.,
2011; Sengupta et al., 2011; Kurn et al., 2005; Head et al., 2011),
showing high uniform representation of transcript coverage and
consistent expression data compared to non-ampliﬁed total RNA.
Despite the fact that we have used GS FLX and ION PGM
sequencing, our strategy is adaptable to other NGS platforms, by
simply designing the appropriate sequencing adaptor based on the
sequence provided by the respective manufacturer, substantially
expanding its application for transcriptional analysis in cancer area.
4. Conclusion
In this study, we presented a new approach to amplify Poly (A)+
RNAs from limited amounts of total RNA, based on linear ampliﬁca-
tion by T7 in vitro transcription and DpnII digestion that allows the
evaluation of whole transcriptomes and also 3′ end RNAseq. The
quantitative aspects of RNAseq from the ampliﬁed libraries were
similar to the non-ampliﬁed Poly (A)+ libraries, revealing adequate
preservation of the transcriptome for comparative analysis.
Additionally, we found high reproducibility of mRNA expression
among tumor samples. Our strategy allows for novel possibilities
when investigating the transcriptome from cell populations of
interest captured from complex tissues.5. Material and methods
5.1. Cell lines and RNA puriﬁcation
The cell lines HB4a and C5.2 were grown as described (Stamps et al.,
1994). HB4a is derived from human mammary luminal epithelial cells
that express basal levels of ERBB2. C5.2 is a clone derived from HB4a
cells transfected with four copies of full-length ERBB2, which is
expressed at high levels (Harris et al., 1999). Total RNA was extracted
with Trizol and treated with DNase I (TURBO DNA-free Kit-Ambion)
as speciﬁed by the manufacturer. RNA quality was assessed using a
Eukaryote Total RNA 2100 Bioanalyzer (Agilent Technologies).
5.2. Ampliﬁed mRNA library construction for whole transcriptome
sequencing and GS FLX (Roche-454) sequencing
Fifty nanograms of total RNAwere incubated with 0.5 μg oligo dT-T7
that contains DpnII and T7 RNA polymerase recognition sites (5′GGCC
GATGAATTGTAATACGACTCACTATAGGGAGGCGGGATCT(30) 3′) at
70 °C for 10 min. Reverse transcription was carried out, as described
(Castro et al., 2008), in the presence of 1.5 μg of the TS-oligo (Matz
et al., 1999) also containing the DpnII restriction site (5′AAGCAGTGGT
AACAACGCAGAGATCGGGCGGG3′). Second strand synthesis was
performed in 1× polymerase buffer, 1× Advantage Polymerase Mix
(Clontech Laboratories), 0.2 mM dNTPs and 2 units RNase H (Life
Technologies). The reaction was incubated at 37 °C for 10 min, 94 °C
for 2min, 62 °C for 3min, 68 °C for 15min and 73 °C for 30min. Puriﬁed
dscDNAswere in vitro transcribedwith the RiboMaxTMLarge Scale RNA
Production System T7 Kit (Promega Corporation), according to the
manufacturer's protocol. Ampliﬁed mRNAs were puriﬁed with the TRI
Reagent (Sigma), and quantiﬁed by the Eukaryote Total RNA 2100
Bioanalyzer (Agilent). First-strand cDNA synthesis was performed as
described above, with the TS and oligo dT primers used for ﬁrst strand
and second strand synthesis, respectively. The cDNA from the ampliﬁed
RNA was used for RNAseq library construction following the same
procedures of cDNA digestion, linker ligation and PCR ampliﬁcation as
previously described for the non-ampliﬁed libraries (Carraro et al.,
2011). Two micrograms of the pooled cDNA libraries (HB4a and C5.2)
were sequenced on the GS FLX (454-Roche).
5.3. Laser capture microdissection of prostate adenocarcinoma samples
Fresh-frozen tumor samples from nine prostate adenocarcinoma
(PCa) patients were retrieved from the ACCamargo Cancer Center
tumor Biobank (Olivieri et al., 2014; Campos et al., 2012). Sections
5 μmthick from the fresh-frozen tumor blockswere cut onto glass slides
226 E.N. Ferreira et al. / Gene 564 (2015) 220–227and H&E-stained. Laser capture microdissection was conducted by an
expert pathologist for isolating the epithelial tumor cells on the
CapSure® HS (Arcturus) using the Pix Cell-II LCM System (Arcturus)
(Supplementary Fig. 3). The capture was conducted in 10 min per sam-
ple and on average, 1280 laser shoots were applied to each sample,
yielding around 3200 cells per capture (considering ~2,5 cells per
laser shoot). Total RNA was extracted by Pico Pure RNA isolation™
Arcturus® and the quality of the RNA were evaluated by RNA 6000
Pico Total RNA Kit on 2100 Bioanalyzer (Agilent Technologies).
5.4. 3′ end RNAseq from ampliﬁed mRNA and ION PGM sequencing
One round of linear mRNA ampliﬁcation was performed with
Arcturus™ RiboAmp® PLUS Kit (Arcturus), yielding about 260 ng of
aRNA per sample (Table 3). The smear range of the ampliﬁed RNA was
inspected with RNA 6000 Pico Total RNA Kit on 2100 Bioanalyzer
(Agilent Technologies, USA) (Table 3). For ﬁrst-strand cDNA synthesis,
aRNA was incubated with 1 μg random oligo (dN15) at 65 °C for 5 min
followed by incubation at 42 °C for 2 h in the presence of SuperscriptIII
(Thermo Scientiﬁc, USA). For second-strand synthesis, we used 0.5 μg
oligo dT containing the Ion-P1 sequencing primer and 5′biotin-labeled.
Reactions were carried out in 1× polymerase buffer, 1× Advantage
Polymerase Mix (Clontech Laboratories), 0.2 mM dNTPs, 1 unit RNase
H (Life Technologies) and incubated at 37 °C for 10 min, 94 °C for
2 min, 62 °C for 3 min, 68 °C for 15 min and 73 °C for 30 min.
The double stranded cDNA was digested with DpnII enzyme as
described (Carraro et al., 2011) and fragments corresponding to the 3 ′
region of transcripts were selected and isolated using streptavidin
coated magnetic particles (Roche, USA). Then, adapters containing the
Ion sequencing primer A and a 6 nt-barcode were ligated to the 5′ end
of the fragments, leading to unidirectional oriented sequencing from
the 5′ extremity. cDNA libraries from the nine PCa sampleswere pooled
and submitted to 5 runs of sequencing on the ION PGM platform
(Thermo Scientiﬁc, USA) using the 318 chip.
5.5. Bioinformatics analyses
Sequencing reads from both 454-GS (Roche, USA) and ION PGM
(Thermo Scientiﬁc, USA) were screened for the presence of adapters.
Reads lacking adapters or presenting internal adapters were removed.
Next, sequences with high similarity to human ribosomal RNA or mito-
chondrial DNA (similarity=0.8 and length fraction=0.5)wereﬁltered
out using the CLC Genomics Workbench 5.1 (CLC Bio, Aarhus,
Denmark). The remaining reads were aligned against the Human
Genome (release hg18 or hg19) and the best alignments were selected
according to the following parameters: minimum similarity = 0.8,
length fraction = 0.5; insertion cost = 3, deletion cost = 3 and mis-
match cost=2. Readswith signiﬁcant hits atmultiple genome locations
were not considered. Reads were also mapped against RefSeq database
by Megablast using the following parameters: minimum similarity =
80% and minimum coverage = 70%. For gene expression analysis, data
were normalized by tags per million.
Graphical analyses were performed using the R package. First
RNAseq readswere distributed over the length of the RefSeq transcripts,
by considering the 5′ end of sequences as “0” and the 3′ end as “100”.
Next, the boxplot was designed given the number of reads positioned
in each range (0–10, 11–20, 21–30, 31–40, 41–50, 51–60, 61–70,
71–80, 81–90, 91–100) plotted against the size of the corresponding
transcripts as previously described (Dias-Neto et al., 2000). For the com-
parison of transcript abundance, the genes common to each library pair
were selected and ranked according to increasing expression values
(reads permillion) based on one of the libraries considered as the refer-
ence. Next, the correspondent expression values from the other library
were obtained for the same transcripts. Genes were grouped by
quantiles, where 0 represents the least abundant and 1.0 represents
the most abundant transcripts, and plotted against the averageexpression log10-transformed values for both libraries in the compari-
son. Finally, we have randomly selected sets of sequences from the am-
pliﬁed mRNA dataset (dashed line) and Poly (A)+ RNA dataset (solid
line) and plotted against the number of different transcripts represent-
ed. We performed this analysis from an initial set of 10,000 until
150,000 reads, in 10,000 read intervals for each set.
We used Spearman's correlation for comparing the RNAseq data
from the nine PCa samples considering the transcripts commonly
represented in all nine libraries. First we obtained the Spearman's
correlation coefﬁcient (R) of each sample against the mean expression
value (considering the nine samples) and then we also calculated
pairwise Spearman's correlations by comparing all nine samples against
each other.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.gene.2015.03.058.Acknowledgments
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